Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
Vir Biotechnology, Inc. VIR

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Apr 10, 2026 8-K 1 signal fired
Core
Management Exodus
Mar 4, 2026 8-K 0 signals fired
No signals above threshold for this filing.
Mar 2, 2026 8-K 3 signals fired
Other
Ipo Net Proceeds Disclosure Ipo Or Capital Raising Completion Institutional Investment
Feb 26, 2026 8-K 7 signals fired
Other
Fcpa Compliance Representation Legal Opinion Scope Limitation Ipo Net Proceeds Disclosure Registration Rights Piggyback Provision Form S3 Shelf Registration Disclosure Hipaa Fraud Abuse Laws Disclosure Closing Logistics Specified
Feb 23, 2026 10-K 83 signals fired · top 15
Core
Regulatory Designation Only Clinical Trial Result
Other
Liquidity Position Snapshot Disclosed Codm Segment Reporting Disclosure Fair Value Hierarchy Disclosure Fcpa Compliance Representation Net Loss Reported Reimbursement Price Pressure Risk Patent Family Portfolio Disclosure Warrant Valued Black Scholes Hipaa Fraud Abuse Laws Disclosure Rsu Psu Vesting Schedule Disclosed Termination For Material Breach Clause Auditor Appointment Ratification Nol Carryforward Expiration Disclosure
Feb 23, 2026 8-K 23 signals fired · top 15
Other
Quarterly Tax Provision Benefit Disclosure Sga Expense Comparison Disclosed Interim Data Positive Net Loss Reported Liquidity Position Snapshot Disclosed Administrative Efficiency Fda Aligned Patient Retention High Burn Rate Controlled Kol Endorsement Enrollment Ahead Of Schedule Publication Positive
Core
Clinical Trial Result Combination Therapy Mentioned Indication Expansion
Jan 12, 2026 8-K 22 signals fired · top 15
Other
Liquidity Position Snapshot Disclosed Interim Data Positive Board Committee Member Listing Publication Positive Expanded Access Program Active Safety Differentiated Enrollment Ahead Of Schedule Transfer And Demand Rights Limitations Fast Track Granted Kol Endorsement Protocol Amended Fast Track Designation Received
Core
Clinical Trial Result Combination Therapy Mentioned Lead Asset Progress
Dec 16, 2025 8-K 19 signals fired · top 15
Core
Regulatory Designation Only Combination Therapy Mentioned Clinical Trial Result Lead Asset Progress Indication Expansion
Other
Fast Track Granted Orphan Status Granted Fast Track Designation Received Enrollment Ahead Of Schedule Patient Retention High Fda Aligned Interim Data Positive Publication Positive Breakthrough Therapy Granted
Biotech Risk
Orphan Drug Designation
Nov 5, 2025 8-K 27 signals fired · top 15
Other
Revenue Decline Explanation Net Loss Reported Enrollment Ahead Of Schedule Sga Expense Comparison Disclosed Interim Data Positive Liquidity Position Snapshot Disclosed Operating Margin Declining Fast Track Granted Administrative Efficiency Fast Track Designation Received
Core
Clinical Trial Result Combination Therapy Mentioned Lead Asset Progress Patient Enrollment Velocity
Business Services
Demand Softening
Nov 5, 2025 10-Q 39 signals fired · top 15
Other
Liquidity Position Snapshot Disclosed Net Loss Reported Hipaa Fraud Abuse Laws Disclosure Depreciation Expense Composition Disclosure Cybersecurity Breach Reputational Harm Disclosure Survival Of Representations Warranties Clause Enrollment Ahead Of Schedule Termination For Material Breach Clause Administrative Efficiency Cash Flow Statement Investing Activities
Core
Regulatory Designation Only Enrollment Failure Patient Enrollment Velocity Clinical Trial Result Combination Therapy Mentioned